Desmosomes: New perpetrators in tumour suppression

Nature Reviews Cancer

Volumn 11, Issue 5, 2011, Pages 317-323

  Dusek, Rachel L ^a   Attardi, Laura D ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; PROTEIN P63;

ARTICLE; CANCER INHIBITION; CANCER INVASION; CELL ADHESION; CELL FUNCTION; CELL JUNCTION; DESMOSOME; DOWN REGULATION; EPITHELIUM; GENETIC ANALYSIS; HOMEOSTASIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 79955405868     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc3051     Document Type: Article

References (135)

1. Cooper, G.M. Oncogenes (Jones and Barlett Publishers, Boston, 1995).
2. Schock, F. & Perrimon, N. Molecular mechanisms of epithelial morphogenesis. Annu. Rev. Cell Dev. Biol. 18, 463-493 (2002). (Pubitemid 35387358)
3. Jamora, C. & Fuchs, E. Intercellular adhesion, signalling and the cytoskeleton. Nature Cell Biol. 4, e101-e108 (2002). (Pubitemid 34308851)
4. Simpson, C.L. & Green, K.J. Desmosomes: new perspectives on a classic. J.Invest. Dermatol. 127, 2499-2515 (2007). (Pubitemid 47585074)
5. Vasioukhin, V., Bauer, C., Yin, M. & Fuchs, E. Directed actin polymerization is the driving force for epithelial cell-cell adhesion. Cell 100, 209-219 (2000). (Pubitemid 30064909)
6. Chen, C.P., Psoy, S., Ben-Shaul, A., Shapiro, L. & Honig, B.H. Specificity of cell-cell adhesion by classical cadherins: critical role for low-affinity dimerization through β-strand swapping. Proc. Natl Acad. Sci. USA 102, 8531-8536 (2005). (Pubitemid 40862770)
7. Nose, A., Tsuji, K. & Takeichi, M. Localization of specificity determining sites in cadherin cell adhesion molecules. Cell 61, 147-155 (1990).
8. Pertz, O. et al. A new crystal structure, Ca2+ dependence and mutational analysis reveal molecular details of E-cadherin homoassociation. EMBO J. 18, 1738-1747 (1999). (Pubitemid 29158518)
9. Yap, A.S., Brieher, W.M. & Gumbiner, B.M. Molecular and functional analysis of cadherin-based adherens junctions. Annu. Rev. Cell Dev. Biol. 13, 119-146 (1997). (Pubitemid 28034522)
10. Ozawa, M., Baribault, H. & Kemler, R. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J. 8, 1711-1717 (1989). (Pubitemid 19273986)
11. Reynolds, A.B. et al. Identification of a new catenin: the tyrosine kinase substrate p120cas associates with E-cadherin complexes. Mol. Cell. Biol. 14, 8333-8342 (1994).
12. Drees, F., Pokutta, S., Yamada, S., Nelson, W.J. & Weis, W.I. α-catenin is a molecular switch that binds E-cadherin-β-catenin and regulates actin-filament assembly. Cell 123, 903-915 (2005). (Pubitemid 41721035)
13. Hulsken, J., Birchmeier, W. & Behrens, J. E-cadherin and APC compete for the interaction with β-catenin and the cytoskeleton. J.Cell Biol. 127, 2061-2069 (1994).
14. Rimm, D.L., Koslov, E.R., Kebriaei, P., Cianci, C.D. & Morrow, J.S. α 1(E)-catenin is an actin-binding and -bundling protein mediating the attachment of F-actin to the membrane adhesion complex. Proc. Natl Acad. Sci. USA 92, 8813-8817 (1995).
15. Rubinfeld, B., Souza, B., Albert, I., Munemitsu, S. & Polakis, P. The APC protein and E-cadherin form similar but independent complexes with α-catenin, β-catenin, and plakoglobin. J.Biol. Chem. 270, 5549-5555 (1995).
16. Yamada, S., Pokutta, S., Drees, F., Weis, W.I. & Nelson, W.J. Deconstructing the cadherin-catenin-actin complex. Cell 123, 889-901 (2005). (Pubitemid 41721034)
17. Behrens, J. et al. Functional interaction of β-catenin with the transcription factor LEF-1. Nature 382, 638-642 (1996). (Pubitemid 26268958)
18. Molenaar, M. et al. XTcf-3 transcription factor mediates β-catenin-induced axis formation in Xenopus embryos. Cell 86, 391-399 (1996). (Pubitemid 26272079)
19. van de Wetering, M. et al. Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell 88, 789-799 (1997).
20. D'Souza-Schorey, C. Disassembling adherens junctions: breaking up is hard to do. Trends Cell Biol. 15, 19-26 (2005). (Pubitemid 40094677)
21. Bremnes, R.M. et al. High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer. J.Clin. Oncol. 20, 2417-2428 (2002). (Pubitemid 34525727)
22. Rakha, E.A., Abd El Rehim, D., Pinder, S.E., Lewis, S.A. & Ellis, I.O. E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance. Histopathology 46, 685-693 (2005). (Pubitemid 40834828)
23. Syrigos, K.N. et al. E-cadherin expression in bladder cancer using formalin-fixed, paraffin-embedded tissues: correlation with histopathological grade, tumour stage and survival. Int. J.Cancer 64, 367-370 (1995). (Pubitemid 26051671)
24. Wijnhoven, B.P., Pignatelli, M., Dinjens, W.N. & Tilanus, H.W. Reduced p120ctn expression correlates with poor survival in patients with adenocarcinoma of the gastroesophageal junction. J.Surg. Oncol. 92, 116-123 (2005). (Pubitemid 41572153)
25. Zheng, Z. et al. Downregulation and abnormal expression of E-cadherin and β-catenin in nasopharyngeal carcinoma: close association with advanced disease stage and lymph node metastasis. Hum. Pathol. 30, 458-466 (1999). (Pubitemid 29177827)
26. Perl, A.K., Wilgenbus, P., Dahl, U., Semb, H. & Christofori, G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392, 190-193 (1998). (Pubitemid 28162793)
27. Derksen, P.W. et al. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 10, 437-449 (2006). (Pubitemid 44693469)
28. Davis, M.A. & Reynolds, A.B. Blocked acinar development, E-cadherin reduction, and intraepithelial neoplasia upon ablation of p120-catenin in the mouse salivary gland. Dev. Cell 10, 21-31 (2006). (Pubitemid 43025674)
29. Perez-Moreno, M., Song, W., Pasolli, H.A., Williams, S.E. & Fuchs, E. Loss of p120 catenin and links to mitotic alterations, inflammation, and skin cancer. Proc. Natl Acad. Sci. USA 105, 15399-15404 (2008).
30. Kobielak, A. & Fuchs, E. Links between α-catenin, NF-κB, and squamous cell carcinoma in skin. Proc. Natl Acad. Sci. USA 103, 2322-2327 (2006). (Pubitemid 43271668)
31. Kobielak, A. & Fuchs, E. α-catenin: at the junction of intercellular adhesion and actin dynamics. Nature Rev. Mol. Cell Biol. 5, 614-625 (2004). (Pubitemid 39025062)
32. Green, K.J. & Gaudry, C.A. Are desmosomes more than tethers for intermediate filaments? Nature Rev. Mol. Cell Biol. 1, 208-216 (2000).
33. Thomason, H.A., Scothern, A., McHarg, S. & Garrod, D.R. Desmosomes: adhesive strength and signalling in health and disease. Biochem. J. 429, 419-433 (2010).
34. Chitaev, N.A. & Troyansovsky, S.M. Direct Ca2+-dependent heterophilic interaction between desmosomal cadherins, desmoglein and desmocollin, contributes to cell-cell adhesion. J.Cell Biol. 138, 193-201 (1997). (Pubitemid 27337463)
35. Heupel, W.M., Zillikens, D., Drenckhahn, D. & Waschke, J. Pemphigus vulgaris IgG directly inhibit desmoglein3-mediated transinteraction. J.Immunol. 181, 1825-1834 (2008).
36. Syed, S.E. et al. Molecular interactions between desmosomal cadherins. Biochem. J. 362, 317-327 (2002).
37. Waschke, J., Bruggeman, P., Baumgartner, W., Zillkens, D. & Drenckhahn, D. Pemphigus foliaceus IgG causes dissociation of desmoglein 1-containing junctions without blocking desmoglein 1 transinteraction. J.Clin. Invest. 115, 3157-3165 (2005). (Pubitemid 41567580)
38. Koeser, J., Troyanovsky, S.M., Grund, C. & Franke, W.W. Denovo formation of desmosomes in cultured cells upon transfection of genes encoding specific desmosomal components. Exp. Cell Res. 285, 114-130 (2003). (Pubitemid 36390160)
39. Nie, Z., Merritt, A., Rouhi-Parkouhi, M., Tabernero, L. & Garrod, D. Membrane-impermeable cross-linking provides evidence for homophilic, isoform-specific binding of desmosomal cadherins in epithelial cells. J.Biol. Chem. 286, 2143-2154 (2011).
40. Runswick, S.K., O'Hare, M.J., Jones, L., Streuli, C.H. & Garrod, D.R. Desmosomal adhesion regulates epithelial morphogenesis and cell positioning. Nature Cell Biol. 3, 823-830 (2001). (Pubitemid 32842688)
41. Witcher, L.L. et al. Desmosomal cadherin binding domains of plakoglobin. J.Biol. Chem. 271, 10904-10909 (1996). (Pubitemid 26149904)
42. Mathur, M., Goodwin, L. & Cowin, P. Interactions of the cytoplasmic domain of the desmosomal cadherin Dsg1 with plakoglobin. J.Biol. Chem., 269, 14075-14080 (1994). (Pubitemid 24191161)
43. Roh, J.Y. & Stanley, J.R. Plakoglobin binding by human Dsg3 (pemphigus vulgaris antigen) in keratinocytes requires the cadherin-like intracytoplasmic segment. J.Invest. Dermatol. 104, 720-724 (1995).
44. Troyanovsky, S.M. et al. Identification of the plakoglobin-binding domain in desmoglein and its role in plaque assembly and intermediate filament anchorage. J.Cell Biol. 127, 151-160 (1994). (Pubitemid 24307664)
45. Bonne, S. et al. Defining desmosomal plakophilin-3 interactions. J.Cell Biol. 161, 403-416 (2003). (Pubitemid 36529857)
46. Chen, X., Bonne, S., Hatzfeld, M., van Roy, F. & Green, K.J. Protein binding and functional characterization of plakophilin 2. Evidence for its diverse roles in desmosomes and β-catenin signaling. J.Biol. Chem. 277, 10512-10522 (2002). (Pubitemid 34968174)
47. Hatzfeld, M., Haffner, C., Schulze, K. & Vinzens, U. The function of plakophilin 1 in desmosome assembly and actin filament organization. J.Cell Biol. 149, 209-222 (2000). (Pubitemid 30196710)
48. Butz, S., Stappert, J., Weissig, H. & Kemler, R. Plakoglobin and b-catenin: distinct but closely related. Science 257, 1142-1144 (1992).
49. McCrea, P.D., Turck, C.W. & Gumbiner, B. A homolog of the armadillo protein in Drosophila (plakoglobin) associated with E-cadherin. Science 254, 1359-1361 (1991). (Pubitemid 21917467)
50. Nathke, I.S., Hinck, L., Swedlow, J.R., Papkoff, J. & Nelson, W.J. Defining interactions and distributions of cadherin and catenin complexes in polarized epithelial cells. J.Cell Biol. 125, 1341-1352 (1994). (Pubitemid 24189537)
51. Zhurinsky, J., Shtutman, M. & Ben-Ze'ev, A. Plakoglobin and β-catenin: protein interaction, regulation and biological roles. J.Cell Sci. 113, 3127-3139 (2000).
52. Conacci-Sorrell, M.E. et al. Nr-CAM is a target gene of the β-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis. Genes Dev. 16, 2058-2072 (2002).
53. Mertens, C., Kuhn, C. & Franke, W.W. Plakophilins 2a and 2b: constitutive proteins of dual location in the karyoplasm and the desmosomsal plaque. J.Cell Biol. 135, 1009-1025 (1996). (Pubitemid 26403775)
54. Bornslaeger, E.A. et al. Plakophilin 1 interferes with plakoglobin binding to desmoplakin, yet together with plakoglobin promotes clustering of desmosomal plaque complexes at cell-cell borders. J.Cell Sci. 114, 727-738 (2001). (Pubitemid 32237145)
55. Kowalczyk, A.P. et al. The amino-terminal domain of desmoplakin binds to plakoglobin and clusters desmosomal cadherin-plakoglobin complexes. J.Cell Biol. 139, 773-784 (1997). (Pubitemid 27485841)
56. Kouklis, P.D., Hutton, E. & Fuchs, E. Making a connection: direct binding between keratin intermediate filaments and desmosomal proteins. J.Cell Biol. 127, 1049-1060 (1994). (Pubitemid 24355992)
57. Smith, E.A. & Fuchs, E. Defining the interactions between intermediate filaments and desmosomes. J.Cell Biol. 141, 1229-1241 (1998). (Pubitemid 28265616)
58. Ihrie, R.A. et al. Perp is a p63-regulated gene essential for epithelial integrity. Cell 120, 843-856 (2005). (Pubitemid 40568801)
59. Attardi, L.D. et al. PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. Genes Dev. 14, 704-718 (2000). (Pubitemid 30176824)
60. Carroll, D.K., Brugge, J.S. & Attardi, L.D. p63, cell adhesion, and survival. Cell Cycle 6, 255-261 (2007).
61. Flores, E.R. et al. Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family. Cell 7, 363-373 (2005). (Pubitemid 40544653)
62. Den, Z., Cheng, X., Merched-Sauvage, M. & Koch, P.J. Desmocollin 3 is required for pre-implantation development of the mouse embryo. J.Cell Sci. 199, 482-489 (2006).
63. Eshkind, L. et al. Loss of desmoglein 2 suggests essential functions for early embryonic development and proliferation of embryonal stem cells. Eur. J.Cell Biol. 81, 592-598 (2002). (Pubitemid 35446792)
64. Gallicano, G.I. et al. Desmoplakin is required early in development for assembly of desmosomes and cytoskeletal linkage. J.Cell Biol. 143, 2009-2022 (1998).
65. Bierkamp, C., Mclaughlin, K.J., Schwarz, H., Huber, O. & Kemler, R. Embryonic heart and skin defects in mice lacking plakglobin. Dev. Biol. 180, 780-785 (1996). (Pubitemid 27037381)
66. Ruiz, P. et al. Targeted mutation of plakoglobin in mice reveals essential functions of desmosomes in the embryonic heart. J.Cell Biol. 135, 215-225 (1996). (Pubitemid 26337749)
67. Koch, P.J. et al. Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J.Cell Biol. 137, 1091-1102 (1997). (Pubitemid 27251044)
68. Vasioukhin, V., Bowers, E., Bauer, C., Degenstein, L. & Fuchs, E. Desmoplakin is essential in epidermal sheet formation. Nature Cell Biol. 3, 1076-1085 (2001). (Pubitemid 33130458)
69. Chidgey, M. et al. Mice lacking desmocollin 1 show epidermal fragility accompanied by barrier defects and abnormal differentiation. J.Cell Biol. 155, 821-832 (2001). (Pubitemid 34286234)
70. Chen, J., Den, Z. & Koch, P.J. Loss of desmocollin 3 in mice leads to epidermal blistering. J.Cell Sci. 121, 2844-2849 (2008).
71. Chidgey, M. Desmosomes and disease: an update. Histol. Histopathol. 17, 1179-1192 (2002).
72. Brennan, D. & Mahoney, M.G. Increased expression of Dsg2 in malignant skin carcinomas: a tissue-microarrary based study. Cell Adh. Migr. 3, 148-154 (2009). 73.
73. Chen, Y.J. et al. DSG3 is overexpressed in head neck cancer and is a potential moelcular target for inhibition of oncogenesis. Oncogene 26, 467-476 (2007).
74. Furukawa, C. et al. Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer. Cancer Res. 65, 7102-7110 (2005). (Pubitemid 41161239)
75. Kurzen, H., Munzing, I. & Hartschuh, W. Expression of desmosomal proteins in squamous cell carcinomas of the skin. J.Cutan. Pathol. 30, 621-630 (2003). (Pubitemid 37372350)
76. Breuninger, S. et al. Desmosomal plakophilins in the prostate and prostatic adenocarcinomas: implications for diagnosis and tumor progression. Am. J.Pathol. 176, 2509-2519 (2010).
77. Alazawi, W.O., Morris, L.S., Stanley, M.A., Garrod, D.R. & Coleman, N. Altered expression of desmosomal components in high-grade squamous intraepithelial lesions of the cervix. Virchows Arch. 443, 51-56 (2003). (Pubitemid 36920951)
78. Alroy, J., Pauli, B.U. & Weinstein, R.S. Correlation between numbers of desmosomes and the aggressiveness of transitional cell carcinoma in human urinary bladder. Cancer 47, 104-112 (1981). (Pubitemid 11167367)
79. de Boer, C.J. et al. Changing roles of cadherins and catenins during progression of squamous intraepithelial lesions in the uterine cervix. Am. J.Pathol. 155, 505-515 (1999). (Pubitemid 29370400)
80. Demirag, G.G., Sullu, Y., Gurgenyatagi, D., Okumus, N.O. & Yucel, I. Expression of plakophilins (PKP1, PKP2, and PKP3) in gastric cancers. Diagn. Pathol. 6, 1 (2011).
81. Harada, T., Shinohara, M., Nakamura, S., Shimada, M. & Oka, M. Immunohistochemical detection of desmosomes in oral squamous cell carcinomas: correlation with differentiation, mode of invasion, and metastatic potential. Int. J.Oral Maxillofac. Surg. 21, 346-349 (1992). (Pubitemid 23031271)
82. Hiraki, A. et al. Immunohistochemical staining of desmosomal components in oral squamous cell carcinomas and its association with tumour behaviour. Br. J.Cancer 73, 1491-1497 (1996). (Pubitemid 26235372)
83. Kocher, O., Amaudruz, M., Schindler, A.M. & Gabbiani, G. Desmosomes and gap junctions in precarcinomatous and carcinomatous conditions of squamous epithelia. An electron microscopic and morphometrical study. J.Submicrosc. Cytol. 13, 267-281 (1981). (Pubitemid 11121557)
84. Nei, H. et al. Expression of component desmosomal proteins in uterine endometrial carcinoma and their relation to cellular differentiation. Cancer 78, 461-470 (1996). (Pubitemid 26250532)
85. Tada, H., Hatoko, M., Tanaka, A., Kuwahara, M. & Muramatsu, T. Expression of desmoglein I and plakoglobin in skin carcinomas. J.Cutan. Pathol. 27, 24-29 (2000). (Pubitemid 30018920)
86. Biedermann, K. et al. Desmoglein 2 is expressed abnormally rather than mutated in familial and sporadic gastric cancer. J.Pathol. 207, 199-206 (2005). (Pubitemid 41404150)
87. Depondt, J., Shabana, A.H., Florescu-Zorila, S., Gehanno, P. & Forest, N. Down-regulation of desmosomal molecules in oral and pharyngeal squamous cell carcinomas as a marker for tumour growth and distant metastasis. Eur. J.Oral Sci. 107, 183-193 (1999).
88. Kahn, K. et al. Desmocollin switching in colorectal cancer. Br. J.Cancer 95, 1367-1370 (2006).
89. Oshiro, M.M. et al. Epigenetic silencing of DSC3 is a common event in human breast cancer. Breast Cancer Res. 7, R669-R680 (2005).
90. Papagerakis, S. et al. Altered desmoplakin expression at transcriptional and protein levels provides prognostic information in human oropharyngeal cancer. Hum. Pathol. 40, 1320-1329 (2009).
91. Shiina, H. et al. Functional loss of the γ-catenin gene through epigenetic and genetic pathways in human prostate cancer. Cancer Res. 65, 2130-2138 (2005). (Pubitemid 40490119)
92. Sobolik-Delmaire, T., Katafiasz, D., Keim, S.A., Mahoney, M.G. & Wahl, J.K. Decreased plakophilin-1 expression promotes increased motility in head and neck squamous cell carcinoma cells. Cell Commun. Adhes. 14, 99-109 (2007). (Pubitemid 47209086)
93. Winn, R.A. et al. γ-catenin expression is reduced or absent in a subset of human lung cancers and re-expression inhibits transformed cell growth. Oncogene 21, 7497-7506 (2002). (Pubitemid 35305577)
94. Yashiro, M., Nishioka, N. & Hirakawa, K. Decreased expression of the adhesion molecule desmoglein-2 is associated with diffuse-type gastric carcinoma. Eur. J.Cancer 42, 2397-2403 (2006). (Pubitemid 44307618)
95. Wong, M.P. et al. Loss of desmoglein1 expression associated with worse prognosis in head and neck squamous cell carcinoma patients. Pathology 40, 611-616 (2008).
96. Collins, J.E., Taylor, I. & Garrod, D.R. A study of desmosomes in colorectal carcinoma. Br. J.Cancer 62, 796-805 (1990). (Pubitemid 20362151)
97. Hakimelahi, S. et al. Plakoglobin regulates the expression of the anti-apoptotic protein BCL-2. J.Biol. Chem. 275, 10905-10911 (2000). (Pubitemid 30212725)
98. Kolligs, F.T. et al. γ-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of β-catenin. Genes Dev. 14, 1319-1331 (2000). (Pubitemid 30397076)
99. Brennan, D. et al. Suprabasal Dsg2 expression in transgenic mouse skin congers a hyperproliferative and apoptosis-resistant phenotype to keratinocytes. J.Cell Sci. 120, 758-771 (2007). (Pubitemid 46523478)
100. Tselepis, C., Chidgey, M., North, A. & Garrod, D. Desmosomal adhesion inhibits invasive behavior. Proc. Natl Acad. Sci. USA 95, 8064-8069 (1998). (Pubitemid 28326066)
101. Simcha, I., Geiger, B., Yehuda-Levenberg, S., Salomon, D. & Ben-Ze'ev, A. Suppression of tumorigenicity by plakoglobin: an augmenting effect of N-cadherin. J.Cell Biol. 133, 199-209 (1996).
102. Reiger-Christ, K.M. et al. Restoration of plakoglobin expression in bladder carcinoma cell lines suppresses cell migration and tumorigenic potential. Br. J.Cancer 92, 2153-2159 (2005).
103. De Bruin, A. et al. Loss of invasiveness in squamous cell carcinoma cells overexpressing desmosomal cadherins. Cell Adhes. Commun. 7, 13-28 (1999).
104. Kundu, S.T. et al. Plakophilin3 downregulation leads to a decrease in cell adhesion and promotes metastasis. Int. J.Cancer 123, 2303-2314 (2008).
105. Caca, K. et al. β- and γ-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer. Cell Growth Differ. 10, 369-376 (1999). (Pubitemid 29284178)
106. Chun, M.G. & Hanahan, D. Genetic deletion of the desmosomal component desmoplakin promotes tumor microinvasion in a mouse model of pancreatic neuroendocrine carcinogenesis. PLoS Genet. 6, e1001120 (2010).
107. Lewis, J.E., Jensen, P. J. & Wheelock, M. J. Cadherin function is required for human keratinocytes to assemble desmosomes and stratify in response to calcium. J.Invest. Dermatol. 102, 870-877 (1994). (Pubitemid 24210381)
108. Beaudry, V.G. et al. Loss of the p53/p63 regulated desmosomal protein Perp promotes tumorigenesis. PLoS Genet. 6, e1001168 (2010).
109. Melnikova, V.O. & Ananthaswamy, H.N. Cellular and molecular events leading to the development of skin cancer. Mutat. Res. 571, 91-106 (2005). (Pubitemid 40313435)
110. Karnovsky, A. & Klymkowsky, M.W. Anterior axis duplication in Xenopus induced by the over-expression of the cadherin-binding protein plakoglobin. Proc. Natl Acad. Sci. USA 92, 4522-4526 (1995).
111. Klymkowsky, M.W., Williams, B.O., Barish, G.D., Varmus, H.E. & Vourgourakis, Y.E. Membrane-anchored plakoglobins have multiple mechanisms of action in Wnt signaling. Mol. Biol. Cell 10, 3151-3169 (1999). (Pubitemid 29489552)
112. Merriam, J.M., Rubenstein, A.B. & Klymkowsky, M.W. Cytoplasmically anchored plakoglobin induces a WNT-like phenotype in Xenopus. Dev. Biol. 185, 67-81 (1997). (Pubitemid 27244218)
113. Miller, J.R. & Moon, R.T. Analysis of the signaling activities of localization mutants of β-catenin during axis specification in Xenopus. J.Cell Biol. 139, 229-243 (1997). (Pubitemid 27444094)
114. Simcha, I. et al. Differential nuclear translocation and transactivation potential of β-catenin and plakoglobin. J.Cell Biol. 141, 1433-1448 (1998). (Pubitemid 28289918)
115. Li, L., Chapman, K., Hu, X., Wong, A. & Pasdar, M. Modulation of the oncogenic potential of β-catenin by the subcellular distribution of plakoglobin. Mol. Carcinog. 46, 824-838 (2007). (Pubitemid 47554279)
116. Salomon, D. et al. Regulation of β-catenin levels and localization by overexpression of plakoglobin and inhibition of the ubiquitin-proteasome system. J.Cell Biol. 139, 1325-1335 (1997). (Pubitemid 27523218)
117. Miravet, S. et al. Tyrosine phosphorylation of plakoglobin causes contrary effects on its association with desmosomes and adherens junction components and modulates β-catenin-mediated transcription. Mol. Cell. Biol. 23, 7391-7402 (2003). (Pubitemid 37211017)
118. Zhurinsky, J., Shtutman, M. & Ben-Ze'ev, A. Differential mechanisms of LEF/TCF family-dependent transcriptional activation by β-catenin and plakoglobin. Mol. Cell. Biol. 20, 4238-4252 (2000). (Pubitemid 30346619)
119. Shtutman, M. et al. The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proc. Natl Acad. Sci. USA 96, 5522-5527 (1999). (Pubitemid 29234650)
120. Williamson, L. et al. Pemphigus vulgaris identifies plakoglobin as key suppressor of c-Myc in the skin. EMBO J. 25, 3298-3309 (2006). (Pubitemid 44141788)
121. Maeda, O. et al. Plakoglobin (γ-catenin) has TCF/LEF family-dependent transcriptional activity in β-catenin-deficient cell line. Oncogene 23, 964-972 (2004). (Pubitemid 38250942)
122. Teuliere, J. et al. β-catenin-dependent and -independent effects of DeltaN-plakoglobin on epidermal growth and differentiation. Mol. Cell. Biol. 24, 8649-8661 (2004). (Pubitemid 39245084)
123. Garcia-Gras, E. et al. Suppression of canonical Wnt/β-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. J.Clin. Invest. 116, 2012-2021 (2006). (Pubitemid 44033325)
124. Li, J. et al. Cardiac tissue-restricted deletion of plakoglobin results in progressive cardiomyopathy and activation of β-catenin signaling. Mol. Cell. Biol. 31, 1134-1144 (2011).
125. Martin, E.D., Moriarty, M.A., Byrnes, L. & Grealy, M. Plakoglobin has both structural and signalling roles in zebrafish development. Dev. Biol. 327, 83-96 (2009).
126. Schmidt, A. et al. Plakophilins 1a and 1b: widespread nuclear proteins recruited in specific epithelial cells as desmosomal plaque components. Cell Tissue Res. 290, 481-499 (1997). (Pubitemid 27522251)
127. Sobolik-Delmaire, T., Reddy, R., Pashaj, A., Roberts, B.J. & Wahl, J.K. Plakophilin-1 localizes to the nucleus and interacts with single-stranded DNA. J.Invest. Dermatol. 130, 2638-2646 (2010).
128. Wolf, A. et al. Plakophilin 1 stimulates translation by promoting eIF4A1 activity. J.Cell Biol. 188, 463-471 (2010).
129. Hofmann, I. et al. Identification of the junctional plaque protein plakophilin 3 in cytoplasmic particles containing RNA-binding proteins and the recruitment of plakophilins 1 and 3 to stress granules. Mol. Biol. Cell 17, 1388-1398 (2006). (Pubitemid 43376558)
130. Papagerakis, S., Shabana, A.H., Depondt, J., Gehanno, P. & Forest, N. Immunohistochemical localization of plakophilins (PKP1, PKP2, PKP3, and p0071) in primary oropharyngeal tumors: correlation with clinical parameters. Hum. Pathol. 34, 565-572 (2003). (Pubitemid 36750368)
131. Berkowitz, P. et al. Desmosome signaling. Inhibition of p38MAPK prevents pemphigus vulgaris IgG-induced cytoskeleton reorganization. J.Biol. Chem. 280, 23778-23784 (2005). (Pubitemid 40884862)
132. Wan, H., South, A.P. & Hart, I.R. Increased keratinocyte proliferation initiated through downregulation of desmoplakin by RNA interference. Exp. Cell Res. 313, 2336-2344 (2007). (Pubitemid 46900938)
133. Garrod, D.R., Berika, M.Y., Bardsley, W.F., Holmes, D. & Tabernero, L. Hyper-adhesion in desmosomes: its regulation in wound healing and possible relationship to cadherin crystal structure. J.Cell Sci. 118, 5743-5754 (2005). (Pubitemid 43079268)
134. Kimura, T.E., Merritt, A.J. & Garrod, D.R. Calcium-independent desmosomes of keratinocytes are hyper-adhesive. J.Invest. Dermatol. 127, 775-781 (2007). (Pubitemid 46434658)
135. Luthra, R. et al. Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation. J.Clin. Oncol. 24, 259-267 (2006). (Pubitemid 46628468)